Resmed announced it has acquired VirtuOx, a leading independent diagnostic testing facility (IDTF) for sleep, respiratory, and cardiac conditions. The acquisition reflects Resmed’s commitment to improving the way care is delivered by making it more accessible, coordinated, and patient-friendly. With VirtuOx’s at-home diagnostic services, Resmed will be better positioned to […]
Acquisitions
Beacon Biosignals to Acquire CleveMed
Beacon Biosignals announced that it has acquired Cleveland Medical Devices Inc. (known as CleveMed), a leader in home sleep testing (HST) technology and services, in a strategic transaction that will strengthen both companies’ capabilities. Jacob Donoghue, MD, PhD, CEO and co-founder of Beacon Biosignals, commented, “There is a lot we […]
Persante Acquires Sleep Management Services Expands National Footprint
Persante Health Care has acquired Sleep Management Services (SMS), a business process outsourcing company specializing in sleep care services across Arkansas and Texas. Funding for the acquisition was provided by Peninsula Capital Partners, a Detroit-based private investment firm that has raised and invested over $2 billion in capital across eight […]
EnsoData Acquires Resonea Sleep Testing Diagnostic Technology
EnsoData announces the acquisition of sleep testing diagnostic technology from Resonea aimed at reducing the cost of systematically addressing sleep apnea across large patient populations. With this acquisition, EnsoData adds acoustic flow and microphone data channels to enable an exciting new way to pre-screen patients for sleep apnea with an […]
ResMed Acquires Somnoware
ResMed today announced the acquisition of privately held Somnoware, a U.S. leader in sleep and respiratory care diagnostics software. Somnoware software streamlines the processes of physicians as well as sleep and pulmonary function testing labs for diagnosing and evaluating a patient’s sleep and respiratory care test results, ordering PAP treatment […]
Nox Health Closes Acquisition of Somryst
Nox Health announced that it has closed the acquisition of Somryst, the first and only FDA-approved prescription digital therapeutic that delivers effective, first-line treatment for adults with chronic insomnia. The addition of Somryst expands Nox Health’s comprehensive suite of tools and programs that address a critical and growing demand for sleep […]
Nox Health Acquires Somryst, The Only FDA Approved Digital Insomnia Treatment
Nox Health has acquired Somryst, the first FDA-cleared Prescription Digital Therapeutic (PDT) that delivers effective, first-line treatment for adults with chronic insomnia. This acquisition deepens the Nox value-based healthcare programs, as it seeks to reframe sleep as a critical and powerful intervention strategy for chronic health conditions management. “The acquisition […]
Industry Insider Pens Book to Transform Dental Sleep Medicne
A new book, Transform Dental Sleep, from dental sleep medicine industry insider Jason Tierney aims to help dentists grow their sleep practices. Over 30,000,000 Americans suffer from obstructive sleep apnea. An unprecedented PAP recall has left millions of people without treatment. 10,000 dentists attended a dental sleep medicine course last year. Less […]
SunMed Completes Acquisition of Vyaire Respiratory & Anesthesia Consumables Business
SunMed, a leading North American manufacturer and distributor of consumable medical devices for anesthesia and respiratory care, today announced the completion of its acquisition of Vyaire Medical’s (“Vyaire”) business unit that manufactures and markets respiratory and anesthesia consumables. Through the combination, SunMed is creating a leading manufacturer wholly dedicated to […]
CAIRE to Acquire MGC Diagnostics Holdings, Inc.
CAIRE Inc., a subsidiary of NGK SPARK PLUG CO., LTD., will acquire St. Paul, Minnesota-based MGC Diagnostics Holdings, Inc. (MGC). MGC designs, develops, manufactures, and markets non-invasive cardiorespiratory diagnostic systems, accessories, and consumables for the detection, classification, and management of cardiorespiratory disease. The acquisition will close by the end of […]












